Wazzup Pilipinas!
Akbayan Youth chairperson Dr. RJ Naguit took a swipe at Presidential spokesperson Harry Roque's statement that healthcare workers who will take the first doses of the government's vaccination program will have to accept China's Sinovac or risk being deprioritized. "Di pwedeng tanggap nang tanggap na lang lalu na kung kalusugan ng mga frontliners natin ang usapin. Sabi ng gobyerno, ang health workers raw ang bayani ng pandemiya, pero bakit parang ang mga doktor, nars, at ibang frontliner ulit ang talo dito?" Dr. RJ Naguit said. "The government is making the questionable Sinovac vaccine a take-it-or-leave-it deal for frontline workers. It’s appalling how they threaten frontliners of being deprioritized and made to line up at the bottom of the list should they refuse to take China's vaccine," Dr. Naguit said. "The list is long for why the public is apprehensive in accepting China's Sinovac. It's touted to be only more than 50% effective in the Brazil clinical trials and it will cost the taxpayer more than double for other brands. The world is cautious in accepting Sinovac because it hasn't been transparent in the final stages of its trials, compared to other vaccines," Naguit said. "Our health workers deserve only the best option and it's the government's job to ensure they get that. Health workers should be allowed to choose their vaccine," Naguit said.
Akbayan Youth chairperson Dr. RJ Naguit took a swipe at Presidential spokesperson Harry Roque's statement that healthcare workers who will take the first doses of the government's vaccination program will have to accept China's Sinovac or risk being deprioritized. "Di pwedeng tanggap nang tanggap na lang lalu na kung kalusugan ng mga frontliners natin ang usapin. Sabi ng gobyerno, ang health workers raw ang bayani ng pandemiya, pero bakit parang ang mga doktor, nars, at ibang frontliner ulit ang talo dito?" Dr. RJ Naguit said. "The government is making the questionable Sinovac vaccine a take-it-or-leave-it deal for frontline workers. It’s appalling how they threaten frontliners of being deprioritized and made to line up at the bottom of the list should they refuse to take China's vaccine," Dr. Naguit said. "The list is long for why the public is apprehensive in accepting China's Sinovac. It's touted to be only more than 50% effective in the Brazil clinical trials and it will cost the taxpayer more than double for other brands. The world is cautious in accepting Sinovac because it hasn't been transparent in the final stages of its trials, compared to other vaccines," Naguit said. "Our health workers deserve only the best option and it's the government's job to ensure they get that. Health workers should be allowed to choose their vaccine," Naguit said.
No comments:
Post a Comment